NASDAQ: IVCAInvestcorp Ai Acquisition Corp Stock
$12.10+0.00 (+0%)
Updated Apr 23, 2025
IVCA Price
$12.10
Fair Value Price
N/A
Market Cap
$96.12M
52 Week Low
$11.25
52 Week High
$12.37
P/E
67.22x
P/B
-20.57x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
$2.33M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.22
Operating Cash Flow
-$734k
Beta
0.02
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
IVCA Overview
Investcorp India Acquisition Corp focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on completing a business combination with a business in any of the consumer, financial, technology, technology-enabled, healthcare, or media sectors primarily in India. The company was formerly known as Investcorp Acquisition Corp. and changed its name to Investcorp India Acquisition Corp in January 2022. Investcorp India Acquisition Corp was incorporated in 2021 and is based in George Town, the Cayman Islands.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine IVCA's potential to beat the market
- IVCA doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Shell Company
Industry Rating
F
IVCA
RankedUnranked of 18
RankedUnranked of 18
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $10.10 | C | |
| $10.09 | C | |
| $10.11 | C |
Be the first to know about important IVCA news, forecast changes, insider trades & much more!
IVCA News
Overview
Due Diligence Score
–
Industry Average (11)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how IVCA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
IVCA was unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
IVCA is poor value based on its earnings relative to its share price (67.22x), compared to the US market average (26.95x)
P/E vs Market Valuation
IVCA is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more IVCA due diligence checks available for Premium users.
Valuation
IVCA price to earnings (PE)
For valuing profitable companies with steady earnings
Company
67.22x
Industry
-26.39x
Market
26.95x
IVCA is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
IVCA is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
IVCA price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-20.57x
Industry
-52.68x
IVCA's financial health
Profit margin
Revenue
$0.0
Net Income
$539.7k
Profit Margin
0%
IVCA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$18.6M
Liabilities
$5.7M
Debt to equity
-1.22
IVCA's short-term liabilities ($5.13M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
IVCA's short-term assets ($1.03M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
IVCA's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
IVCA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$50.6k
Investing
-$150.0k
Financing
$1.2M
IVCA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
IVCA vs Shell Company Stocks
Investcorp Ai Acquisition Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.